Cargando…
Analysis of Serum miRNA Profiles of Myasthenia Gravis Patients
Myasthenia gravis (MG) is an autoimmune disease characterized by the presence of autoantibodies, mainly against the acetylcholine receptor (AChR). The mechanisms triggering and maintaining this chronic disease are unknown. MiRNAs are regulatory molecules that play a key role in the immune system and...
Autores principales: | Nogales-Gadea, Gisela, Ramos-Fransi, Alba, Suárez-Calvet, Xavier, Navas, Miquel, Rojas-García, Ricard, Mosquera, Jose Luis, Díaz-Manera, Jordi, Querol, Luis, Gallardo, Eduard, Illa, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956820/ https://www.ncbi.nlm.nih.gov/pubmed/24637658 http://dx.doi.org/10.1371/journal.pone.0091927 |
Ejemplares similares
-
Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy
por: Querol, Luis, et al.
Publicado: (2017) -
The impact of rituximab infusion protocol on the long‐term outcome in anti‐MuSK myasthenia gravis
por: Cortés‐Vicente, Elena, et al.
Publicado: (2018) -
Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome
por: Cortés‐Vicente, Elena, et al.
Publicado: (2022) -
Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies
por: Siles, Ana M., et al.
Publicado: (2018) -
Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis
por: Álvarez-Velasco, Rodrigo, et al.
Publicado: (2023)